Blood vessels

Histology for Pathologists: Fourth Edition

Volumn , Issue , 2012, Pages

  Gallagher, Patrick J ^a   Van Der Wal, Allard C ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84962527025     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (91)

1. Ferrari AU, Radaelli A, Centola M. Invited review: aging and the cardiovascular system. J Appl Physiol 2003;95:2591-2597.
2. Plante GE. Impact of aging on the body's vascular system. Metabolism 2003;52(suppl 2):31-35.
3. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a 'set up' for vascular disease. Circulation 2003;107:139-146.
4. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic basis of arterial stiffness. Hypertension 2005;45:1050-1055.
5. Kentish JC. Smooth muscle and the cardiovascular and lymphatic systems. In: Stranding S, ed. Gray's Anatomy: The Anatomical Basis of Clinical Practice. 40th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2008:127-144.
6. Jacob MP. Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother 2003;57:195-202.
7. Kavurma MM, Bhindi R, Lowe HC, et al. Vessel wall apoptosis and atherosclerotic plaque instability. J Thromb Haemostasis 2005;3:465-472.
8. Boddaert J, Mallat Z, Fornes P, et al. Age and gender effects on apoptosis in the human coronary arterial wall. Mech Ageing Dev 2005;126:678-684.
9. Clarke MC, Littlewood TD, Figg N, et al. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ Res 2008;192:1529-1538.
10. Roijers RB, Debernardi N, Cleutjens JP, et al. Microcalcifications in early intimal lesions of atherosclerotic human coronary arteries. Am J Pathol 2011. [Epub ahead of print]
11. Jono S, Shioi A, Ikari Y, et al. Vascular calcification in chronic kidney disease. J Bone Miner Metab 2006;24:176-181.
12. Maier W, Altwegg LA, Corti R, et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 2005;111:1355-1361.
13. Mucchiano GI, Haggqvist B, Sletten K, et al. Apolipoprotein A-1-derived amyloid in atherosclerotic plaques of the human aorta. J Pathol 2001;193:270-275.
14. Schlatmann TJ, Becker AE. Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm. Am J Cardiol 1977;39:13-20.
15. Hsue PY, Salinas CL, Bolger AF, et al. Acute aortic dissection related to crack cocaine. Circulation 2002;105:1592-1595.
16. Ihling C, Szombathy T, Nampoothiri K, et al. Cystic medial degeneration of the aorta is associated with p53 accumulation, Bax upregulation, apoptotic cell death, and cell proliferation. Heart 1999;82:286-293.
17. Gelb BD. Marfan's syndrome and related disorders-more tightly connected than we thought. N Engl J Med 2006;355:841-842.
18. Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-β receptor. N Engl J Med 2006;355:788-798.
19. Judge DP, Dietz HC. Marfan's syndrome. Lancet 2005;366:1965-1976.
20. Jain D, Dietz HC, Oswald GL, et al. Causes and histopathology of ascending aortic disease in children and young adults. Cardiovasc Pathol 2011;20:15-25.
21. Hinterseher I, Tromp G, Kuivaniemi H. Genes and abdominal aortic aneurysm. Ann Vasc Surg 2011;25:388-412.
22. Kuivaniemi H, Shibamura H, Arthur C, et al. Familial aortic aneurysms: collection of 233 multiplex families. J Vasc Surg 2003;37:340-345.
23. Walker M, Gallagher PJ. The surgical pathology of large vessel disease. Diagn Histopathol 2010;16:10-16.
24. Ryder HF, Tafe LJ, Burns CM. Fatal aortic dissection due to fulminant variety of isolated aortitis. J Clin Rheumatol 2009;15:295-299.
25. Stone JR. Aortitis, periaortitis and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol 2011;23:88-94.
26. Nirula A, Glaser SM, Kalled Sl, et al. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol 2011;23:119-124.
27. Szyszka-Mroz J, Wozniak W. A histological study of human ductus arteriosus during the last embryonic week. Folia Morphol (Warsz) 2003;62:365-367.
28. Anderson RH, Becker AE, Robertson WB. The arterial duct. In: Symmers WS, ed. The Cardiovascular System Part A. New York, NY: Churchill Livingstone; 1993:1193, 197-202.
29. Stary HC, Blankenhorn DH, Chandler AB, et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1992;85:391-405.
30. Kim C, Redberg RF, Pavlic T, et al. A systematic review of gender differences in mortality after coronary artery bypass graft surgery and percutaneous interventions. Clin Cardiol 2007;30:491-495.
31. Antoniadis AP, Chatzizisis YS, Giannoglou GD. Pathogenetic mechanisms of coronary ectasia. Int J Cardiol 2008;130:335-343.
32. Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349:2316-2325.
33. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275.
34. van der Wal AC. Coronary artery pathology. Heart 2007;93:1484-1489.
35. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011;364:226-235.
36. Redgrave JNE, Lovett JK, Gallagher PJ, et al. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms. Circulation 2006;113:2320-2328.
37. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007;356:830-840.
38. Hammes HP. Pericytes and the pathogenesis of diabetic retinopathy. Horm Metab Res 2005;37(suppl 1):39-43.
39. Ashgar O, Al-Sunni A, Khavandi K, et al. Diabetic Cardiomyopathy. Clin Sci 2009;116:741-760.
40. Richards OC, Raines SM, Attie AD. The role of blood vessels, endothelial cells and vascular pericytes in insulin secretion and peripheral insulin activity. Endocrine Rev 2010;31:343-363.
41. Hayasaka H, Taniguchi K, Fukai S, et al. Neogenesis and development of the high endothelial venules that mediate lymphocyte trafficking. Cancer Sci 2010;101:2302-2308.
42. Owens CD. Adaptive changes in autologous vein grafts for arterial reconstruction: clinical implications. J Vasc Surg 2010;51:736-746.
43. Langes K, Hort W. Intimal fibrosis (phlebosclerosis) in the saphenous vein of the lower limb: a quantitative analysis. Virchows Arch A Pathol Anat Histopathol 1992;421:127-131.
44. Mooi WJ, Grünberg K. Histopathology of pulmonary hypertensive diseases. Curr Diagn Pathol 2006;12:429-440.
45. Patchefsky AS. Nonneoplastic pulmonary disease. In: Mills SE, ed. Sternberg's Diagnostic Surgical Pathology. 5th ed. Vol 1. Philadelphia, PA: Lippincott Williams & Wilkins; 2009:1035-1039.
46. Warnock ML, Kunzmann A. Changes with age in muscular pulmonary arteries. Arch Pathol Lab Med 1977;101:175-179.
47. Steiner I, Hajkova P, Kvasnicka J, et al. Myocardial sleeves of pulmonary vein and atrial fibrillation: a postmortem histopathological study on 100 subjects. Virchows Arch 2006;449:88-95.
48. Gombos Z, Zhang PJ. Glomus tumor. Arch Pathol Lab Med 2008;132:1448-1452.
49. Warkentin TE, Moore JC, Anand SS, et al. Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Transfus Med Rev 2003;17:272-286.
50. Baxter M, Aly EH. Dieulafoy's lesion:current trends in diagnosis and management. Ann R Coll Surg Engl 2010;92:548-554.
51. Boon LM, Ballieux F, Vikkula M. Pathogenesis of vascular anomalies. Clin Plastic Surg 2011;38:7-19.
52. Pardali E, Goumans MJ, ten Dijke P. Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol 2010;20:556-567.
53. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-422.
54. Cahill AM, Nijs EL. Pediatric vascular malformations: pathophysiology, diagnosis, and the role of interventional radiology. Cardiovasc Intervent Radiol 2011;34:691-704.
55. Dompmartin A, Vikkula M, Boon LM. Venous malformation: update on aetiopathogenesis, diagnosis and management. Phlebology 2010;25:224-235.
56. Calonje E. Haemangiomas. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organisation Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:156-158.
57. Rerkasam K, Rothwell PM. Systematic review of the operative risks of carotid endarterectomy for recently symptomatic stenosis in relation to the timing of surgery. Stroke 2009;40:e564-e572.
58. Riles TS, Rockman CB. Cerebrovascular disease. In: Townsend CM, Beauchamp RD, Evers BM, Mattox KL eds. Sabiston Textbook of Surgery. 18th ed. Philadelphia, PA: WB Saunders; 2008:1895-1899.
59. Garratt KN, Edwards WD, Kaufmann UP, et al. Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and saphenous vein bypass grafts: analysis of tissue obtained from 73 patients by directional atherectomy. J Am Coll Cardiol 1991;17:442-448.
60. Kalan JM, Roberts WC. Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-millimetre segments of veins. Am Heart J 1990;119:1164-1184.
61. Jeremy JY, Gadsdon P, Shukla N, et al. On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents. Biomaterials 2007;28:895-908.
62. Parang P, Arora R. Coronary vein graft disease: pathogenesis and prevention. Can J Cardiol 2009;25:e57-e62.
63. Ali E, Saso S, Ahmed K, et al. When harvested for coronary artery bypass surgery, does a skeletonised or pedicled radial artery improve conduit patency? Interactive Cardiovasc Thorac Surg 2010;10:289-292.
64. D'Souza SP, Mamas MA, Fraser DG, et al. Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST elevation myocardial infarction: a meta analysis. Eur Heart J 2011;32:972-982.
65. Popma JJ, Bhatt DL. Percutaneous coronary and valvular intervention. In: Bonow R, Mann DL, Zipes DP, Libby P, eds. Braunwald's Heart Disease. 9th ed. Philadelphia, PA: Elsevier Saunders; 2011:1270-1300.
66. Garcia-Garcia HM, Gonzalo N, Regar E, et al. Virtual histology and optical coherence tomography: from research to a broad clinical application. Heart 2009;95:1362-1374.
67. Bradshaw SH, Kennedy L, Dexter DF, et al. A practical method to rapidly dissolve metallic stents. Cardiovasc Pathol 2009;18:127-133.
68. Kapadia MR, Popowich DA, Kibbe MR. Modified prosthetic vascular conduits. Circulation 2008;117:1873-1882.
69. Reitsma S, Slaaf DW, Vink H, et al. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch-Eur J Physiol 2007;454:345-359.
70. Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 2004;84:869-901.
71. Van Itallie CM, Anderson JM. The molecular physiology of tight junction pores. Physiology (Bethesda) 2004;19:331-338.
72. Hsueh WA, Quinones MJ. Role of endothelial dysfunction in insulin resistance. Am J Cardiol 2003;92:10J-17J.
73. Kirschner N, Bohner C, Rachow S, et al. Tight junctions: is there a role in dermatology. Arch Dermatol Res 2010;302:483-493.
74. Baum B, Georgiou M. Dynamics of adherens junctions in epithelial establishment, maintenance and remodeling. J Cell Biol 2011;192:907-917.
75. Maeda S, Tsukihara T. Structure of the gap junction channel and its implications for its biological functions. Cell Mol Life Sci 2011;68:1115-1129.
76. Hesketh GG, Van Eyk JE, Tomaselli GF. Mechanisms of gap junction traffic in health and disease. J Cardiovasc Pharm 2009;54:263-272.
77. Chidlow JH, Sessa WC. Caveolae, caveolins and cavins: complex control of cellular signaling and inflammation. Cardiovasc Res 2010;86:219-225.
78. Valentijn KM, Sadler JE, Valentijn JA, et al. Functional architecture of Weibel-Palade bodies. Blood 2011;117:5033-5043.
79. Aird WC. Phenotypic heterogenity of the endothelium. II. Representative vascular beds. Circ Res 2007;100:174-190.
80. Giepmans BN. Gap junctions and connexin-interacting proteins. Cardiovasc Res 2004;62:233-245.
81. Dales JP, Garcia S, Carpentier S, et al. Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n = 905). Br J Cancer 2004;90:1216-1221.
82. Kumar S, Ghellal A, Li C, et al. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 1999;59:856-861.
83. North PE, Waner M, Mizeracki A, et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000;31:11-22.
84. Jackson DG. Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. APMIS 2004;112:526-538.
85. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol 2002;15:434-440.
86. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 2005;13:7-12.
87. Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005;352:1685-1695.
88. Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med 2003;349:160-169.
89. Meijer-Jorna LB, Mekkes JR, van der Wal AC. Platelet involvement in cutaneous small vessel vasculitis. J Cutan Pathol 2002;29:176-180.
90. Arbustini E, Morbini P, D'Armini AM, et al. Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation. Heart 2002;88:177-182.
91. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture. Angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005;25:2054-2061.